CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026
  1. CFO Spotlights
  2. Profiles
  3. Vinay Shah

Profile

Vinay Shah

Chief Financial Officer (Principal Financial and Accounting Officer), Adial Pharmaceuticals, Inc.

Former. First published here October 28, 2026; built from records as of October 28, 2026.

Adial Pharmaceuticals, Inc. reported the departure of Vinay Shah from the chief financial officer seat, with an effective date the filing does not state.2

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Adial Pharmaceuticals, Inc. (ADIL)
Pharmaceutical Preparations
Chief Financial Officer (Principal Financial and Accounting Officer)Former2

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. Date not statedfiled August 13, 2026

    Adial Pharmaceuticals, Inc. reported the departure of Vinay Shah from the chief financial officer seat, with an effective date the filing does not state.

    the Company anticipates that the employment of its current Chief Financial Officer, Vinay Shah, will be terminated effective promptly after the 2026 Annual Meeting if Stockholder Approval is obtained, and that a new Chief Financial Officer will be appointed.

    [2] Filing by Adial Pharmaceuticals, Inc., filed with the SEC on August 13, 2026. Read the filing. The record at CFO Tribune.

  2. March 5, 202610-K filed

    Vinay Shah signed the annual report of Adial Pharmaceuticals, Inc. on Form 10-K as Chief Financial Officer (Principal Financial and Accounting Officer), filed March 5, 2026.

    /s/ Vinay Shah Chief Financial Officer March 5, 2026 Vinay Shah (Principal Financial and Accounting Officer)

    [1] Annual report on Form 10-K by Adial Pharmaceuticals, Inc., filed with the SEC on March 5, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Annual report on Form 10-K, Adial Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed March 5, 2026. sec.gov; record.
  2. Current report filed with the SEC, Adial Pharmaceuticals, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed August 13, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Vinay Shah wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.